Zenas BioPharma Eyes US IPO Amid Investor Optimism
Bristol-Myers Squibb-backed Zenas BioPharma files for US IPO as market hopes for rate cuts and reduced volatility rise.
- Latest
- Trending
Bristol-Myers Squibb-backed Zenas BioPharma files for US IPO as market hopes for rate cuts and reduced volatility rise.
Nepal ends TikTok ban after ByteDance addresses cyber crime concerns, ensuring user safety and content regulation.
Exploring Microsoft's recent segment changes to align with strategic goals, highlighting shifts within M365 and Azure.
Cava's stock hits record as Q2 results loom. Sales expected to rise, driven by new menu items.
Delta invests $100M in MSP to enhance routes and tech, reinforcing MSP as a world-class hub and boosting Minnesota's economy.
Cisco calls for revisions to the UN's cyber crime convention, citing potential threats to human rights and free speech.
Citigroup finances $46.9M for Sinatra-led purchase of Cocoa Grand, a 268-unit complex in Florida, enhancing their real estate portfolio.
Morgan Stanley favors Japan and India stocks, cuts China outlook amid weak growth and persistent deflation concerns.
Metaverse tech in education to grow from $3.9B to $19.3B by 2028, revolutionizing learning with VR and AR innovations.
Germany's tax revenue fell 7.9% in July but rose 1.9% Jan-Jul 2023, reaching 477.8B euros. Analysts predict growth in 2024.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.